Literature DB >> 7035499

Tumour-associated eosinophilia: a review.

D Lowe, J Jorizzo, M S Hutt.   

Abstract

In a recent study of cervical carcinoma, 13 cases with a marked eosinophil infiltrate around the tumour were found. The histological appearance of the tumours was distinctive and suggested a specific response, similar to the lymphocyte infiltration in medullary carcinoma of the breast and seminoma. A review of published reports shows that tumour-associated tissue eosinophilia (TATE) and tumour-associated blood eosinophilia (TABE) may be seen in tumours of different histological types from different anatomical sites, and may occur together or separately. Tumours with TATE alone appear to have a better prognosis that those without, while TABE is associated with tumor spread and a poor prognosis.

Entities:  

Mesh:

Year:  1981        PMID: 7035499      PMCID: PMC494593          DOI: 10.1136/jcp.34.12.1343

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  63 in total

1.  Eosinophilia encountered in female genital organs.

Authors:  D M DIVACK; N A JANOVSKI
Journal:  Am J Obstet Gynecol       Date:  1962-09-15       Impact factor: 8.661

2.  Tumor-associated eosinophilotactic factor.

Authors:  S I Wasserman; E J Goetzl; L Ellman; K F Austen
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

3.  Syndrome associated with pancreatic acinar cell carcinoma.

Authors:  J C Robertson; G H Eeles
Journal:  Br Med J       Date:  1970-06-20

4.  Leukaemoid reaction and eosinophilia in "inflammatory fibrous histiocytoma".

Authors:  J R Vilanova; J Burgos-Bretones; R Simón; J M Rivera-Pomar
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

5.  Eosinophils, pleural effusions, and malignancy.

Authors:  S C Deresinski
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

6.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

7.  Eosinophil leucocytes and recovery from severe hypoxia.

Authors:  Y D Sibley; G Hudson
Journal:  Acta Haematol       Date:  1970       Impact factor: 2.195

8.  Eosinophilia associated with metastatic carcinoma.

Authors:  L R Sataline; E Mobley
Journal:  Ohio State Med J       Date:  1967-11

9.  New concepts on the action of oestrogens in the uterus and the role of the eosinophil receptor system.

Authors:  A Tchernitchin; X Tchernitchin; P Galand
Journal:  Differentiation       Date:  1976-06-04       Impact factor: 3.880

10.  In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.

Authors:  S Cohen; P A Ward
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

View more
  59 in total

1.  Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C.

Authors:  S Arinaga; N Karimine; K Takamuku; S Nanbara; H Inoue; R Abe; D Watanabe; H Matsuoka; H Ueo; T Akiyoshi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Eosinophils in health and disease: the LIAR hypothesis.

Authors:  J J Lee; E A Jacobsen; M P McGarry; R P Schleimer; N A Lee
Journal:  Clin Exp Allergy       Date:  2010-04       Impact factor: 5.018

3.  Eosinophil cationic protein in urine in patients with urinary bladder tumors.

Authors:  G Lose; B Frandsen
Journal:  Urol Res       Date:  1989

4.  The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG).

Authors:  Ljubomir R Jakovic; Biljana S Mihaljevic; Maja D Perunicic Jovanovic; Andrija D Bogdanovic; Vesna M Cemerikic Martinovic; Tamara K Kravic; Vladimir Z Bumbasirevic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

5.  Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study.

Authors:  Jennifer L Steel; Kevin H Kim; Mary Amanda Dew; Mark L Unruh; Michael H Antoni; Marion C Olek; David A Geller; Brian I Carr; Lisa H Butterfield; T Clark Gamblin
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

6.  Severe eosinophilia associated with a malignant islet cell tumour.

Authors:  J H Haldane; H Kapoor; J Morris
Journal:  CMAJ       Date:  1989-05-01       Impact factor: 8.262

Review 7.  Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options.

Authors:  Paneez Khoury; Bruce S Bochner
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Sep - Oct

8.  GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation.

Authors:  Colleen S Curran; Michael D Evans; Paul J Bertics
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

9.  Tumour-Associated Tissue Eosinophilia in Oral Squamous Cell Carcinoma- A Boon or a Bane?

Authors:  Shweta Yellapurkar; Srikant Natarajan; Karen Boaz; Mohan Baliga; Premalatha Shetty; Nidhi Manaktala; Mukul Prasad; Mahalakshmi Ravi
Journal:  J Clin Diagn Res       Date:  2016-04-01

10.  Interstitial collagenase gene expression in colonic neoplasia.

Authors:  S T Gray; K Yun; T Motoori; Y M Kuys
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.